0,937  0,005  Antiinflammatory
0,767  0,005  Bone diseases treatment
0,763  0,003  Hedgehog signaling inhibitor
0,745  0,002  Vanilloid agonist
0,726  0,005  Antiosteoporotic
0,681  0,005  Angiogenesis stimulant
0,658  0,018  Analgesic
0,630  0,004  Insulin secretagoues
0,627  0,019  Alzheimer's disease treatment
0,618  0,010  Antiepileptic
0,615  0,011  Immunosuppressant
0,604  0,009  Nitric oxide antagonist
0,602  0,011  Immunomodulator
0,624  0,044  Apoptosis agonist
0,589  0,026  Antileukemic
0,559  0,006  Myocardial infarction treatment
0,562  0,009  Antineurogenic pain
0,562  0,014  Hepatic disorders treatment
0,543  0,005  Sleep disorders treatment
0,527  0,007  Antineoplastic (liver cancer)
0,533  0,018  Cardioprotectant
0,527  0,025  Antipruritic, allergic
0,512  0,025  Anxiolytic
0,479  0,017  Antiglaucomic
0,467  0,005  Antiviral (Influenza A)
0,467  0,025  Antineoplastic (pancreatic cancer)
0,488  0,046  Transcription factor NF kappa B inhibitor
0,445  0,004  TRPA1 agonist
0,454  0,014  Sedative
0,450  0,011  UGT1A4 substrate
0,462  0,044  CYP2C9 substrate
0,418  0,009  Antiviral (Influenza)
0,408  0,005  Autism spectrum disorders treatment
0,469  0,069  Antineoplastic (solid tumors)
0,418  0,020  Dependence treatment
0,392  0,008  Antineoplastic (gastric cancer)
0,414  0,033  Antioxidant
0,415  0,034  Apoptosis antagonist
0,416  0,037  Antipsoriatic
0,431  0,055  Antiobesity
0,380  0,009  Acaricide
0,429  0,065  Antibacterial
0,391  0,042  Antineoplastic (melanoma)
0,363  0,014  Antiacne
0,352  0,007  Antifungal enhancer
0,393  0,048  Antifungal
0,375  0,037  UGT2B4 substrate
0,354  0,017  Antihypotensive
0,400  0,065  Antineoplastic (lung cancer)
0,363  0,032  Sodium/bile acid cotransporter inhibitor
0,361  0,031  Antiparasitic
0,351  0,023  Antihelmintic
0,360  0,033  Antidiabetic symptomatic
0,332  0,005  Antifungal (Cryptococcus)
0,343  0,019  UGT2B7 substrate
0,338  0,017  VCAM1 expression inhibitor
0,344  0,025  Antiparkinsonian, rigidity relieving
0,384  0,067  CYP3A4 substrate
0,359  0,044  Calcium channel activator
0,319  0,005  T cell inhibitor
0,332  0,017  Antipruritic, non-allergic
0,379  0,066  Cognition disorders treatment
0,345  0,037  Mutagenic
0,309  0,004  Posttraumatic stress disorder treatment
0,384  0,084  TNF expression inhibitor
0,315  0,018  Interferon gamma antagonist
0,333  0,035  Psychostimulant
0,296  0,004  Inducible nitric-oxide synthase inhibitor
0,311  0,021  Melanin inhibitor
0,315  0,026  P-glycoprotein inhibitor
0,352  0,065  Antineoplastic (colorectal cancer)
0,339  0,054  Teratogen
0,327  0,044  Cardiovascular analeptic
0,365  0,085  Rheumatoid arthritis treatment
0,302  0,022  Diabetic retinopathy treatment
0,332  0,055  CYP2C19 substrate
0,379  0,103  Cyclophilin D inhibitor
0,379  0,103  Antidiabetic
0,293  0,020  Prostate disorders treatment
0,295  0,024  Pneumotoxic
0,288  0,022  CYP2B6 inhibitor
0,382  0,122  Caspase 9 stimulant
0,285  0,025  Antianorexic
0,326  0,068  Antineoplastic (colon cancer)
0,294  0,036  Abortion inducer
0,284  0,029  Antialcoholic
0,327  0,073  Antithrombotic
0,307  0,054  Sensitization
0,268  0,016  UGT2B9 substrate
0,301  0,051  Antineoplastic (renal cancer)
0,296  0,051  GST M1-1 substrate
0,281  0,036  RNA-directed DNA polymerase inhibitor
0,260  0,016  Cholesterol synthesis inhibitor
0,251  0,009  Constipation treatment
0,299  0,059  Embryotoxic
0,318  0,078  ICAM1 expression inhibitor
0,296  0,057  NOS2 expression inhibitor
0,289  0,051  5 Hydroxytryptamine uptake stimulant
0,278  0,039  Anesthetic general
0,242  0,006  Vanilloid 1 agonist
0,305  0,070  Antineoplastic (endocrine cancer)
0,243  0,010  Microtubule formation inhibitor
0,304  0,073  Analeptic
0,256  0,025  Protein kinase stimulant
0,300  0,074  NOS3 expression inhibitor
0,330  0,105  Antineoplastic (breast cancer)
0,296  0,072  Spasmolytic
0,259  0,044  UGT1A1 substrate
0,247  0,034  Lipocortins synthesis antagonist
0,296  0,090  FMO1 substrate
0,246  0,044  Non-steroidal antiinflammatory agent
0,269  0,068  Antipyretic
0,250  0,052  Chemopreventive
0,205  0,009  Nitric-oxide synthase inhibitor
0,219  0,024  Protein-tyrosine phosphatase 1B inhibitor
0,264  0,074  Chemoprotective
0,211  0,030  Acetylcholinesterase inhibitor
0,210  0,030  UGT2B10 substrate
0,210  0,031  Antidiarrheal
0,221  0,044  Eye irritation, high
0,203  0,030  Arachidonic acid antagonist
0,175  0,006  5-Alpha-reductase inhibitor
0,232  0,067  Cytotoxic
0,172  0,009  Antiviral (Coronavirus)
0,172  0,009  Antiviral (SARS coronavirus)
0,202  0,039  Interleukin 6 antagonist
0,194  0,033  SULT1A3 substrate
0,241  0,079  Tumour necrosis factor alpha release inhibitor
0,205  0,044  Cholinergic
0,199  0,040  Anesthetic
0,172  0,015  Prolactin inhibitor
0,258  0,102  CTGF expression inhibitor
0,239  0,084  Proliferative diseases treatment
0,196  0,044  Contraceptive
0,163  0,012  Aromatase inhibitor
0,245  0,095  Antineoplastic (ovarian cancer)
0,180  0,030  Movement disorders treatment
0,167  0,018  Androgen antagonist
0,172  0,024  Antiemetic
0,176  0,031  Farnesoid X receptor antagonist
0,158  0,014  Anabolic
0,211  0,067  Neurotrophic factor enhancer
0,158  0,014  CYP2A6 inhibitor
0,259  0,119  Cholesterol antagonist
0,254  0,114  Interleukin 2 agonist
0,189  0,051  Protein-tyrosine phosphatase inhibitor
0,242  0,106  Respiratory analeptic
0,155  0,019  Neutropenia treatment
0,231  0,102  Lipoprotein disorders treatment
0,166  0,042  Skin irritative effect
0,128  0,005  TRPM8 blocker
0,229  0,106  Gastrin inhibitor
0,145  0,022  Actinic keratosis treatment
0,157  0,035  Interleukin 1b antagonist
0,192  0,070  Hepatoprotectant
0,187  0,066  Sigma receptor agonist
0,154  0,033  Ca2+-transporting ATPase inhibitor
0,152  0,032  Contraceptive female
0,133  0,013  ATPase (Vacuolar H+) inhibitor
0,130  0,010  Glycine receptor agonist
0,125  0,008  Hypercalcemia treatment
0,219  0,103  Interleukin agonist
0,164  0,048  Neurotrophic factor
0,150  0,035  SULT1A1 substrate
0,144  0,032  Antineoplastic antibiotic
0,215  0,104  Antineoplastic (sarcoma)
0,165  0,055  CNS active muscle relaxant
0,209  0,099  Antihypercholesterolemic
0,167  0,058  UGT2B15 substrate
0,205  0,095  Cytostatic
0,133  0,024  UGT2B11 substrate
0,161  0,051  Bone formation stimulant
0,117  0,010  Androgen agonist
0,247  0,145  Ulceration
0,202  0,100  Antineoplastic (cervical cancer)
0,127  0,025  Tourette's syndrome treatment
0,116  0,014  TRPA1 antagonist
0,130  0,032  Interleukin 2 antagonist
0,099  0,005  Retinoid X receptor agonist
0,106  0,013  Vanilloid 4 agonist
0,242  0,148  GST A substrate
0,148  0,055  Skin whitener
0,182  0,090  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,095  0,004  Parathyroid hormone antagonist
0,227  0,136  AR expression inhibitor
0,220  0,128  CYP1A2 substrate
0,191  0,102  UGT1A6 substrate
0,204  0,117  DNA synthesis inhibitor
0,123  0,036  GST T1-1 substrate
0,165  0,078  ATPase inhibitor
0,112  0,029  Antibiotic
0,103  0,021  Hyperparathyroidism treatment
0,107  0,026  Na+ K+ transporting ATPase inhibitor
0,126  0,046  GABA C receptor agonist
0,126  0,048  Choleretic
0,198  0,121  Immunostimulant
0,146  0,069  Antiparkinsonian, tremor relieving
0,086  0,010  Postcoital contraceptive
0,150  0,075  Hearing loss treatment
0,108  0,034  Bile acid receptor antagonist
0,131  0,057  Growth stimulant
0,115  0,042  UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor
0,154  0,081  Uterine stimulant
0,077  0,005  5-Alpha-reductase 1 inhibitor
0,119  0,049  UGT2B1 substrate
0,136  0,069  Interleukin 1 antagonist
0,105  0,039  Ornithine decarboxylase inhibitor
0,131  0,066  Antiseptic
0,197  0,132  UGT1A9 substrate
0,150  0,088  Prostatic (benign) hyperplasia treatment
0,068  0,006  5-Alpha-reductase 2 inhibitor
0,148  0,087  Carcinogenic, group 1
0,151  0,090  Muscle relaxant
0,090  0,030  Cannabinoid receptor agonist
0,080  0,020  Cannabinoid CB2 receptor antagonist
0,140  0,080  Adenylate cyclase stimulant
0,128  0,069  Antihyperlipoproteinemic
0,161  0,102  UDP-glucuronosyltransferase substrate
0,157  0,098  Platelet adhesion inhibitor
0,064  0,007  Alpha 1L adrenoreceptor agonist
0,059  0,002  Vanilloid 2 agonist
0,066  0,009  Microtubule stabilization
0,153  0,097  Carcinogenic
0,089  0,034  SULT1A2 substrate
0,082  0,027  Cannabinoid CB1 receptor agonist
0,065  0,010  Retinoid X alpha receptor agonist
0,126  0,071  Antismoking
0,126  0,072  Retinoprotector
0,141  0,087  Raynaud's phenomenon treatment
0,095  0,044  Transcription factor NF kappa B stimulant
0,082  0,031  Anticholelithogenic
0,055  0,005  Vanilloid 3 antagonist
0,135  0,086  Pregnane X receptor agonist
0,077  0,028  Glutamate (mGluR6) antagonist
0,194  0,146  Tyrosine 3 hydroxylase inhibitor
0,124  0,076  Renal failure treatment
0,056  0,008  Retinoid X receptor antagonist
0,118  0,070  DNA polymerase I inhibitor
0,118  0,071  Antiviral (Influenza B)
0,113  0,067  Photosensitizer
0,138  0,093  UGT1A3 substrate
0,064  0,019  Anesthetic inhalation
0,066  0,020  Nicotinic alpha3beta2 receptor antagonist
0,050  0,005  Adenosine uptake inhibitor
0,139  0,094  Neuropathy treatment
0,122  0,080  Amylase inhibitor
0,049  0,007  Retinoid X alpha receptor antagonist
0,044  0,003  Progesterone receptor B antagonist
0,155  0,115  Antirickettsial
0,104  0,064  Expectorant
0,069  0,030  Cannabinoid CB2 receptor agonist
0,107  0,068  GABA C receptor antagonist
0,074  0,036  SULT2A1 substrate
0,117  0,080  Alpha-N-acetylglucosaminidase inhibitor
0,165  0,129  VEGF expression inhibitor
0,091  0,056  Antidote, mercury
0,040  0,005  Vitamin D receptor antagonist
0,043  0,012  Tubulin agonist
0,107  0,077  Anesthetic local
0,084  0,054  Estrogen-related receptor beta agonist
0,083  0,053  CC chemokine 5 receptor agonist
0,114  0,084  Cyclooxygenase 3 inhibitor
0,096  0,068  Sulfotransferase substrate
0,064  0,038  Prolactin release inhibitor
0,059  0,033  Pregnane X receptor antagonist
0,058  0,033  Dihydroorotate oxidase inhibitor
0,051  0,026  Cytokine production stimulant
0,063  0,041  Antimycoplasmal
0,078  0,057  Antidote, organophosphates
0,032  0,011  Nicotinic acid receptor 2 antagonist
0,142  0,123  Phospholipase C inhibitor
0,272  0,253  Ca2+/calmodulin-dependent protein kinase kinase A inhibitor
0,053  0,035  Aconitate hydratase inhibitor
0,035  0,017  Glutamate (mGluR3) agonist
0,130  0,112  Antihelmintic (Nematodes)
0,028  0,010  Nociceptin (N/OFQ) receptor agonist
0,025  0,007  Retinoid X beta receptor antagonist
0,077  0,061  Glycine receptor antagonist
0,023  0,007  Nicotinic acid receptor 1 antagonist
0,057  0,041  Lipocortins synthesis agonist
0,029  0,013  Toll-Like receptor 4 agonist
0,068  0,052  Cannabinoid receptor antagonist
0,052  0,038  Protein 50S ribosomal subunit inhibitor
0,027  0,012  CYP24 inhibitor
0,186  0,173  Metabolic disease treatment
0,106  0,094  Alcohol dehydrogenase substrate
0,035  0,024  Growth factor receptor-bound protein 2 antagonist
0,072  0,062  Keratolytic
0,145  0,135  Anticonvulsant
0,137  0,128  Interleukin antagonist
0,057  0,048  Cannabinoid CB1 receptor antagonist
0,072  0,063  Narcotic antagonist
0,078  0,069  Sleep apnea treatment
0,086  0,078  Lanosterol 14 alpha demethylase inhibitor
0,019  0,012  Progesterone agonist
0,033  0,026  Progesterone antagonist
0,050  0,044  Nicotinic receptor alpha7 subunit antagonist
0,035  0,030  2,3-Oxidosqualene-lanosterol cyclase inhibitor
0,090  0,086  Antiprotozoal (Toxoplasma)
0,058  0,054  Heme oxygenase stimulant
0,136  0,132  LDLR expression enhancer
0,164  0,161  5 Hydroxytryptamine release stimulant
0,026  0,023  Hedgehog signaling activator
0,026  0,023  Retinoid X gamma receptor antagonist
0,038  0,037  Histamine H2 receptor agonist
0,035  0,034  GABA uptake inhibitor
0,015  0,014  Vitamin D receptor agonist
0,063  0,063  Calcium channel L-type blocker

